Am J Transplant, Volume 18, Suppl 3 Archives - Page 206 of 211 - ATC Abstracts

2018 American Transplant Congress
Eluates from Fine-Needle Allograft Biopsy Increase Donor-Specific Antibody Identification in Antibody Mediated Rejection
A. Girnita,^1,2 E. Portwood,² P. Brailey,² M. Cuffy,¹ M. Cardi,¹ F. Paterno,¹ T. Diwan,¹ S. Shah,¹ A. Govil,¹ R. Alloway,¹ E. Woodle.¹
¹University of Cincinnati, Cincinnati; ²Hoxworth Blood Center, Cincinnati.
Aim. Antibody mediated rejection (AMR) represents a risk for graft loss, and the presence of circulating donor-specific antibody (cDSA) is a major criterion for AMR…
2018 American Transplant Congress
Impact of De Novo DSA (DnDSA) on Outcomes in HLA-Sensitized (HS) Patients Transplanted after IVIG + Rituximab Desensitization (DES)
A. Vo,¹ O. Aubert,² H. Edmund,¹ A. Peng,¹ R. Najjar,¹ S. Supreet,¹ J. Choi,¹ K. Lim,¹ S. Jordan.¹
¹Kidney Transplant, Cedars-Sinai Medical Center, LA, CA; ²Paris Translational Research Center for Organ Transplantation, Necker Hospital, Paris, France.
Introduction: Highly-HLA sensitized patients (HS) with donor specific antibodies (DSA) at transplant are at risk for Type 1 ABMR. However, the incidence of Type 2…
2018 American Transplant Congress
Impact of Bw4 and Bw6 Epitope Mismatch on Clinical Outcomes after Renal Transplantation
C. Liu,¹ D. Brennan,² K. Lentine,³ R. Delos Santos,¹ J. Li,¹ A. Malone,¹ T. Alhamad.¹
¹Washington University in St. Louis, St. Louis; ²Johns Hopkins University, Baltimore; ³Saint Louis University, St. Louis.
HLA class II epitope mismatch has been shown to impact the long-term survival of kidney allografts. HLA-B alleles are traditionally grouped by the Bw4 and…
2018 American Transplant Congress
Pre-Emptive Rituximab and Intravenous Immunoglobulin (IVIg) Fail to Prevent Rejection in Kidney Transplant Recipients (KTx) with Donor Specific Antibodies (DSA)
J. Crew, R. Vasilescu, E. Campenot, S. Mohan, S. Patel.
Columbia University, New York, NY.
Introduction:IVIg and Rituximab have been used successfully to improve transplantation rates in sensitized patients. DSA detected by Flow crossmatch (FXM+) or Luminex® at time of…
2018 American Transplant Congress
Standard- versus Low-Dose Valganciclovir for Cytomegalovirus Prophylaxis in Intermediate-Risk Kidney Transplant Recipients
N. Wilson, N. Sulejmani, A. Jantz, A. Patel, B. Summers.
Henry Ford Hospital, Detroit, MI.
Background: Although guidelines recommend valganciclovir (VGC) 900 mg daily for cytomegalovirus (CMV) prophylaxis in solid organ transplant patients, multiple centers have reported clinical success, reduced…
2018 American Transplant Congress
Retrospective Study of Cryptococcosis in Kidney Transplant Recipients from a Single Center
R. Wang, M. Cen, J. Lin, H. Huang, W. Peng, J. Wu.
Kidney Disease Center, The First Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang, China.
Background: The mortality of Cryptococcosis remains unchanged among kidney transplant recipients(KTR) over the past two decades, and the prognosis of Cryptococcosis is yet unpredicted. Hence,…
2018 American Transplant Congress
Effect of Everolimus on Body Composition; 1-Year after Kidney Transplantation
M. Yoshikawa,¹ T. Ishimura,² S. Nishi.¹
¹Division of Nephrology, Kobe University Graduate School of Medicine, Kobe, Japan; ²Division of Urology, Kobe University Graduate School of Medicine, Kobe, Japan.
【Background】Weight gain, and especially visceral fat gain early after kidney transplantation has a worse outcome for metabolic disorder, graft function, and cardiovascular disease. The mammalian…
2018 American Transplant Congress
The Incidence and Outcome of Isolated Distal Deep Vein Thrombosis in Kidney Transplant Recipient
M. Kim, J. Hwang, S. Kim, S. Park, I. Moon, J. Kim.
Surgery, The Catholic University of Korea, Seoul, Republic of Korea.
Introduction Isolated distal deep vein thrombosis (IDDVT) in kidney transplantation recipient (KTR) is difficult to make decision because it is not common in Korean and…
2018 American Transplant Congress
Liver Retransplantation and Renal Failure: The Benefit of Simultaneous Kidney Transplant
J. Berumen,¹ V. Irine,² S. Mita,² S. Gabriel,¹ M. Kristin.¹
¹Department of Surgery, University of California San Diego, San Diego, CA; ²Department of Medicine, University of California San Diego, San Diego, CA.
Liver retransplantation has poor survival compared to primary liver transplant. Renal failure is a proven negative risk factor for survival with retransplant. Our aim was…
2018 American Transplant Congress
Re-Transplantation for Hepatic Artery Thrombosis: A National Perspective
C. Garcia, X. Mei, F. Marti, M. Shah, J. Berger, M. Daily, M. Gupta, R. Gedaly.
Surgery, University of Kentucky, Lexington.
Background: We aim to analyze patients undergoing re-transplantation for HAT in the US.Methods:Between 1995 and 2015, 623 patients were re-transplanted for HAT identified in the…